Skip to main content
Log in

Can databasing optimise patient care?

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract.

Long-term, prospective databasing of multiple sclerosis (MS) information provides a useful resource for natural history studies. Furthermore, it is the only way to address the question of whether early treatment eliminates or delays the inevitable and irreversible clinical worsening that is the hallmark of the late phase of the illness. Due to the variable nature of MS, it is useful to monitor large numbers of individuals over time. The limitations of single databases may be overcome by regional, national or international pooling of data. In this paper, the Italian Multiple Sclerosis Database Network (MSDN) and the international web-based MSBase registry are described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ (1992) EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 55:671–676

    CAS  PubMed  Google Scholar 

  2. Koch-Henriksen N (1999) The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 5:293–296

    Article  CAS  PubMed  Google Scholar 

  3. Paty D, Studney D, Redekop K, Lublin F (1994) MS COSTAR: a computerized patient record adapted for clinical research purposes. Ann Neurol 36 (Suppl):S134–S135

    PubMed  Google Scholar 

  4. Schroder M (1999) MUSIS 2.0—Multiple Sclerosis Information System: an easy-to-use-database to improve the care of patients with multiple sclerosis. Mult Scler 5:297–298

    Article  PubMed  Google Scholar 

  5. Millefiorini E, Gasperini C, Pozzilli C, D’Andrea F, Bastianello S, Trojano M, Morino S, Morra VB, Bozzao A, Calo’ A, Bernini ML, Gambi D, Prencipe M (1997) Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol 244:153–159

    Article  CAS  PubMed  Google Scholar 

  6. Trojano M, Avolio C, Manzari C, Calo A, De Robertis F, Serio G, Livrea P (1995) Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry 58:300–306

    CAS  PubMed  Google Scholar 

  7. Trojano M, Liguori M, Bosco Zimatore G, Bugarini R, Avolio C, Paolicelli D, Giuliani F, De Robertis F, Marrosu MG, Livrea P (2002) Age-related disability in multiple sclerosis. Ann Neurol 51:475–480

    Article  PubMed  Google Scholar 

  8. Trojano M, Liguori M, Paolicelli D, Bosco Zimatore G, De Robertis F, Avolio C, Giuliani F, Fuiani A, Livrea P and the Southern Italy MS Group Interferon-Beta in Relapsing-Remitting MS (2003) An independent postmarketing study in Southern Italy. Mult Scler 9:451–457

    Article  CAS  PubMed  Google Scholar 

  9. Butzkueven H, Chapman J, Cristiano E, Grand’Maison F, Izquierdo G, Kappos L, Leist T, Poehlau D, Rivera V, Trojano M, Verheul F on behalf of the MS Base Scientific Advisory Board (2003) MSBase: an international, online registry dedicated to evaluating outcomes data in multiple sclerosis. Mult Scler 9 (Suppl 1):S6–S42

    Article  Google Scholar 

  10. Weinshenker BG (1999) Databases in MS research: pitfalls and promises. Mult Scler 5:206–211

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Trojano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trojano, M. Can databasing optimise patient care?. J Neurol 251 (Suppl 5), v79–v82 (2004). https://doi.org/10.1007/s00415-004-1513-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-004-1513-x

Key words

Navigation